Silgan Hldgs: Q2 Earnings Insights

  Silgan Hldgs (NASDAQ:SLGN) reported its Q2 earnings results on Wednesday, July 27, 2022 at 07:15 AM. Here's what investors need to know about the announcement.

 

Silgan Hldgs (NASDAQ:SLGN) reported its Q2 earnings results on Wednesday, July 27, 2022 at 07:15 AM.

Here’s what investors need to know about the announcement.

Earnings

Silgan Hldgs beat estimated earnings by 12.5%, reporting an EPS of $1.08 versus an estimate of $0.96.

Revenue was up $195.00 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 1.1% increase in the share price the next day.

Here’s a look at Silgan Hldgs’s past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate 0.76 0.73 1.04 0.83
EPS Actual 0.78 0.79 1.02 0.85
Revenue Estimate 1.38B 1.36B 1.60B 1.29B
Revenue Actual 1.44B 1.44B 1.65B 1.35B

To track all earnings releases for Silgan Hldgs visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

MoonLake Immunotherapeutics’ Lead Skin Disorder Candidate Continues to Deliver on Best-Efficacy Profile: Analyst

MoonLake Immunotherapeutics (NASDAQ: MLTX) announced 24-week topline results from its Phase 2 MIRA trial of sonelokimab for moderate-to-severe hidradenitis suppurativa (HS), following the 12-week results, in which the primary endpoint was met with 29 percentage points delta 

MLTX